Toshihide Tanaka Naoki Kato Kuniaki Itoh Yuzuru Hasegawa
10.2176/nmc.cr2013-0095
Neurol Med Chir (Tokyo)
2014;54(8):677-80.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/24305022/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Cecal Neoplasms / drug therapy Cecal Neoplasms / pathology Cranial Nerve Neoplasms / drug therapy Cranial Nerve Neoplasms / pathology Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, Large B-Cell, Diffuse / pathology Rituximab / administration & dosage Survivors Trigeminal Nerve Diseases / drug therapy Trigeminal Nerve Diseases / pathology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Cecal Neoplasms / drug therapy Cecal Neoplasms / pathology Cranial Nerve Neoplasms / drug therapy Cranial Nerve Neoplasms / pathology Lymphoma, Large B-Cell, Diffuse / drug therapy Lymphoma, Large B-Cell, Diffuse / pathology Rituximab / administration & dosage Survivors Trigeminal Nerve Diseases / drug therapy Trigeminal Nerve Diseases / pathology Case Reports Cecal Neoplasms / diagnosis Chemotherapy, Adjuvant Combined Modality Therapy Cranial Nerve Neoplasms / diagnosis Cyclophosphamide / therapeutic use Cytarabine / therapeutic use Dexamethasone / therapeutic use Etoposide / therapeutic use Humans Lymphoma, Large B-Cell, Diffuse / diagnosis Male Middle Aged Trigeminal Nerve Diseases / diagnosis Cytarabine Rituximab Etoposide Dexamethasone Cyclophosphamide CHASE protocol
PMC4533500
24305022
Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report
2014